Protein test to guide treatment for upper stomach cancer
Part of Cancer, Digestive system clinical trials.
This study looks at proteins in your blood to find different types of stomach cancer. The goal is to match you with the best treatment before surgery, which may improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with stomach cancer that starts in the upper part of the stomach or near the junction with the esophagus.
- Your cancer is at a stage where it can be removed with surgery, but you have not had any prior treatment for it.
- You are generally healthy and able to manage daily activities (score of 80 or higher on a standard scale).
- You have not had significant bleeding, blockages, or other serious medical conditions that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study tests a new way to guide treatment after surgery for stomach cancer. It uses a blood test to look for tiny pieces of cancer DNA, and then gives extra treatment only to people who still have signs of cancer. The goal is to prevent the cancer from coming back.
This study is testing whether a simple blood test can help find stomach cancer early, before symptoms appear. This could offer a less invasive way to detect the disease compared to a scope procedure.
This study tests whether giving treatment based on the specific markers of your tumor can better control advanced stomach cancer. The goal is to match the right therapy to each person's cancer.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.